ClinicalTrials.Veeva

Menu

Esophagus Deviation During Radiofrequency Ablation of Atrial Fibrillation - EASY AF STUDY

S

S4 Medical

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Device: esolution catheter

Study type

Interventional

Funder types

Industry

Identifiers

NCT04659213
EASY AF

Details and patient eligibility

About

To assess if deviating the esophagus will reduce/eliminate ablation injury to the esophagus.

Enrollment

129 patients

Sex

All

Ages

22 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male or female age ≥ 22 years and < 80 years
  • Clinical decision to proceed with AF ablation procedure.
  • Ablation procedure to be completed with General Anesthesia
  • Ablation procedure to be completed with use of radiofrequency catheter ablation

Exclusion criteria

  • History of various esophageal pathology such as esophageal achalasia, varices, strictures, web, carcinoma, tumor/mass, scleroderma, Mallory-Weiss tear, Barrett's esophagitis, diverticulum, banding, laceration, perforation, balloon dilatation.
  • Presence of a pH probe deployed in the esophagus
  • Planned AF ablation procedure to be completed with laser energy or with cryo-energy
  • Acute or uncontrolled psychiatric illness
  • Unable to undergo upper endoscopy
  • Enrollment in another FDA clinical trial
  • Unstable medical condition(s) that precludes safely completing study protocol
  • Subject is incarcerated
  • Subject is pregnant
  • Subject is unable to comprehend the details of the study
  • The Investigator believes that the subject will be unwilling or unable to comply with study protocol requirements, including the investigational device procedure and study-related follow up visit requirements

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

129 participants in 2 patient groups

Interventional Group
Experimental group
Description:
Placement of a luminal esophageal temperature probe (LET) and insertion of esolution esophageal retractor. In the intervention group, esolution will be utilized to deviate the esophagus during RF catheter ablation
Treatment:
Device: esolution catheter
Control Group
No Intervention group
Description:
Placement of a luminal esophageal temperature probe (LET) during RF ablation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems